Search

everythinglearnresearchcommunity

for

Search:↓

Adding Triamcinolone to the anesthetic can reduce swelling after hair transplants, and using Platelet-Rich Plasma can improve hair thickness and patient satisfaction. The SRD5A2 gene also plays a key role in the success of hair transplants.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

A 16-year-old boy's arm hair grew more after wearing a splint, but it returned to normal in 8 months.

Hair restoration surgery redistributes existing hair to achieve a natural look, with visible regrowth in 3-4 months and rare complications, mostly aesthetic.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

Platelet-rich plasma treatment is effective for hair loss in patients regardless of their thyroid antibody levels.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

In India, most patients with type 1 autoimmune polyglandular failure show symptoms in a specific order, starting with parathyroid gland issues, then yeast infections, and finally adrenal gland failure.

Transplanting beard hair into a scalp wound after hair transplant surgery improves scar appearance and hair keeps its normal traits.

Alopecia areata patients are more likely to have thyroid disorders than healthy individuals.

The 2-step surgery effectively treats stable follicular vitiligo with high patient satisfaction and no major complications.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Triamcinolone acetonide injections help regrow hair in alopecia areata patients.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Tissue expansion for head and neck reconstruction has good blood supply and doesn't need capsule removal, but expect temporary hair loss with normal growth resuming after 6-8 months.

The combined treatment improved hair growth and scalp health in a patient with scalp alopecia from birth.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Controlling Tslp can improve health in AEC syndrome patients.

Autologous mini-punch grafting can effectively repigment stable vitiligo, but has some risks and limitations.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.

Frozen-thawed fibroblast sheets enhance wound healing and hair growth in mice.

A 68-year-old woman with lupus and blood disorders improved after increased steroids and immunoglobulin treatment.

A woman developed alopecia after her second Pfizer vaccine but regrew her hair with treatment and had no issues after a booster shot.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

The model and estimator can predict drug exposure in kidney transplant patients well.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.